Literature DB >> 19479712

Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?

Sinclair M Gore1, Maria Kasper, Tomos Williams, Gerhard Regl, Fritz Aberger, Reno Cerio, Graham W Neill, Michael P Philpott.   

Abstract

Although deregulated Hedgehog signalling and elevated Gli transcription factor expression are known to promote the development of basal cell carcinoma (BCC), little is known about molecular mechanisms driving the development of specific growth pattern subtypes. Using gene array analysis, we have previously observed that over-expression of GLI1 in human keratinocytes promotes increased expression of the neuronal differentiation markers ARC and ULK1. We asked whether neuronal differentiation is a characteristic of BCC and whether there is any correlation with BCC subtype. Using RT-PCR and immunohistochemistry, we confirmed that the neuronal markers ARC, beta-tubulin III, GAP-43 and Neurofilament are expressed in human BCC but not in normal epidermis. Moreover, we found that expression of these neuronal differentiation markers showed strong correlation to BCC subtype, with more aggressive infiltrative and morphoeic BCC showing low levels or lack of expression compared to nodular, superficial and micronodular subtypes. Primary human keratinocytes retrovirally expressing GLI1(-) and GLI2(-) showed elevated levels of beta-tubulin III and ARC but not Neurofilament or GAP-43, suggesting that beta-tubulin III and Arc may be early targets of aberrant Gli expression in BCC, whereas expression of Neurofilament and GAP-43 are either later, downstream targets or under control of alternative pathways. We propose that neuronal differentiation is a feature of BCC and that expression of these markers is in part due to aberrant Hedgehog signalling. Moreover, we suggest that correlation between loss of expression of neuronal markers in infiltrative and morphoeic BCC subtypes reflects dedifferentiation of more aggressive BCC subtypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479712     DOI: 10.1002/path.2568

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

Review 1.  UNC51-like kinase 1, autophagic regulator and cancer therapeutic target.

Authors:  Y Chen; J He; M Tian; S-Y Zhang; M-R Guo; R Kasimu; J-H Wang; L Ouyang
Journal:  Cell Prolif       Date:  2014-10-20       Impact factor: 6.831

2.  Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors.

Authors:  Mohammad-Ali Yazdani Abyaneh; Peter Engel; Andrzej Slominski; Bruce Ragsdale; Richard Agag; Daniel Cramer; J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2017-03       Impact factor: 1.533

3.  Immunohistochemistry: relevance in dermatology.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

4.  GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.

Authors:  Shingo Inaguma; Miho Riku; Hideaki Ito; Takumi Tsunoda; Hiroshi Ikeda; Kenji Kasai
Journal:  Oncotarget       Date:  2015-10-20

5.  Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers.

Authors:  David J Duffy; Christine Schnitzler; Lorraine Karpinski; Rachel Thomas; Jenny Whilde; Catherine Eastman; Calvin Yang; Aleksandar Krstic; Devon Rollinson; Bette Zirkelbach; Kelsey Yetsko; Brooke Burkhalter; Mark Q Martindale
Journal:  Commun Biol       Date:  2018-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.